FDA Seeks Feedback On Brain-Computer Interface Devices For Amputees
This article was originally published in The Gray Sheet
The agency has scheduled a November workshop on brain-computer interface devices to discuss scientific, clinical and regulatory considerations for firms designing neuroprostheses that work with the central nervous system to help restore motor capabilities in paralyzed and amputee patients. The meeting could inform development of a draft guidance.
You may also be interested in...
Brain-computer interface device makers should consider customer accessibility and clinicians’ ability to deploy the BCI system to get to market, Medtronic technology director says at an FDA meeting. New brain-machine interface include products to help paraplegics walk and people with tremors to grasp tools used in daily life.
FDA approved an advanced prosthetic arm from Deka R&D Corp. May 9 that has the ability to translate electrical signals from muscle into complex tasks.
Biogen value-based contract with UPMC Health Plan ties payments to patient-reported outcomes for Tecfidera and Avonex. The company may seek something similar for Vumerity.